More about

Sulfasalazine

Clinical Guidance
Ulcerative Colitis
Assessment and Treatment

Aminosalicylate Therapy

Gary R. Lichtenstein, MD, FACP, FACG, AGA; Robert B Stein, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Rheumatoid Arthritis
Treatment Options

Corticosteroid Therapy

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
December 02, 2020
2 min read
Save

Evidence inconclusive for immunosuppressing drugs’ influence on men’s sexual health

Evidence inconclusive for immunosuppressing drugs’ influence on men’s sexual health

A systematic review of 161 studies showed a lack of conclusive evidence on the influence and safety of immunosuppressive drugs on male sexual health, according to a study published in Human Reproduction Update.

News
November 03, 2020
30 min listen
Save

Inflammatory Bowel Disease for the Rheumatologist

Inflammatory Bowel Disease for the Rheumatologist

How common is asymptomatic bowel involvement in patients with peripheral or axial SpA? Can we use NSAIDs in these patients? What’s the difference between sulfasalazine and mesalamine? Hear what a rheumatologist should know about IBD!

News
May 27, 2020
3 min read
Save

Triple therapy inferior to TNF plus methotrexate for persistence, RA disease activity outcomes

Triple therapy inferior to TNF plus methotrexate for persistence, RA disease activity outcomes

Combination therapy with TNF inhibitors plus methotrexate was significantly superior to triple therapy with methotrexate, hydroxychloroquine and sulfasalazine in patients with rheumatoid arthritis, both in terms of persistence and improved disease activity, according to data published in Arthritis Care & Research.

News
November 15, 2019
2 min read
Save

Ultrasound-guided treatment strategy shows no benefit in early RA

Ultrasound-guided treatment strategy shows no benefit in early RA

ATLANTA — Data from a 2-year, randomized controlled trial presented here demonstrate that using ultrasound findings to guide early rheumatoid arthritis treatment strategy did not reduce MRI inflammation or result in less structural damage.